investors with losses of $100,000 Contact the law firm for free to learn more about recovering their losses

LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) — The law firm of Portnoy advises TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) TGTX Investors that a class action lawsuit has been filed on behalf of investors. TG Therapeutics investors who have lost money investing are encouraged to do so Contact Lesley Portnoy, Esq.

Investors are encouraged to contact an attorney Lesley F Portnoyby phone 844-767-8529 or E-mail: [email protected]to discuss your legal rights, or click here to join the case about www.portnoylaw.com. Portnoy Law Firm can provide a free case assessment and discuss investors’ options for making claims to recover their losses.

The lawsuit alleges that the defendants made materially false and misleading statements regarding the Company’s business, operations and compliance policies throughout the class period. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) clinical trials revealed significant concerns about the benefit-risk balance and overall survival data of ubituximab and umbralisib; (2) accordingly, it was unlikely that the Company would receive FDA approval for umbralisib MZL/FL NDA, U2 BLA, U2 sNDA, or ubituximab RMS BLA in their current forms; (3) as a result, the company had significantly overstated the clinical and/or commercial prospects of ubituximab and umbralisib; and (4) therefore, at all relevant times, the Company’s public statements were materially false and misleading.

Please visit our website to verify further information and to submit your transaction information.

Portnoy Law Firm represents investors in asserting claims against companies caused by wrongdoing. The firm’s founding partner has recovered over $5.5 billion for aggrieved investors. attorney advertising. Previous results do not guarantee similar results.

Lesley F….